Phase 3 Ovarian Cancer Trial, Not Yet Recruiting NCT06980545 Sponsor: Assiut University Condition: Ovarian Cancer
Back to Ovarian Cancer

Phase 3 Ovarian Cancer Trial, Not Yet Recruiting

NCT06980545
Not Yet Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are older than 18 years of age
  • You have recently been diagnosed with stage III or stage IV ovarian cancer
  • You are able to receive a type of chemotherapy that contains platinum (confirm with trial site)
  • After 3 to 4 cycles of chemotherapy given before surgery, your cancer has either partially responded to treatment or stayed stable (not grown)

Who may not be able to join:

  • Your ovarian cancer has come back after previous treatment (relapsed)
  • You are unable to receive platinum-based chemotherapy for any reason
  • You are not considered a suitable candidate for interval debulking surgery (a surgery to remove as much of the cancer as possible, done after chemotherapy)
  • You have been diagnosed with stage I or stage II ovarian cancer
  • Your cancer got worse or continued to grow after 3 cycles of chemotherapy
  • You were unable to tolerate or cope with chemotherapy treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +201013736679

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
30 June 2025
Est. completion
30 April 2026

Primary endpoints

event free survival

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov